fig1
From: Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
![Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma](https://image.oaes.cc/95d97a06-9c1e-4152-83bf-65cd13a83297/3694.fig.1.jpg)
Figure 1. Receiver operating characteristic curves for pre-treatment NLR (A) and PLR (B) in predicting non-response to TARE. The cutoff points for pre-treatment NLR and PLR were 2.83 and 83, respectively. Arrows depict selected cutoff points. NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; AUC: area under the curve; CI: confidence interval; TARE: transarterial radioembolization